Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society of Blood and Marrow Transplantation

Hôpitaux de Brabois, CHRU Nancy, and CNRS, Biopôle de l’Université de Lorraine, Vandoeuvre les Nancy
King's College Hospital-NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK and King's College London
EBMT Statistical Unit, Leiden
EBMT Leiden Study Unit, Leiden
Armed Forces Bone MarrowTransplant Centre, Rawalpindi
Armed Forces Bone MarrowTransplant Centre, Rawalpindi
Saint James, Leeds teaching Hospitals NHS trust, Leeds
Ospedale Policlinico San martino. Genova
Akdeniz University Medical School Antalya
Institut d'Hematologie et d'Oncologie Pediatrique, Debrousse Hospital, Lyon
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan
CHU de Lille, University of Lille, INSERM U1286, Lille
King Faisal Specialist Hospital and Research Centre Riyadh
Clinica Pediatrica Università degli Studi Milano Bicocca, San Gerardo Hospital, Monza
IRCCS Istituto Giannina Gaslini, Genoa
Institut de cancérologie Strasbourg Europe (ICANS), Strasbourg
Hospital Clinico Universitario de Valencia Valencia Spain
St. George's Hospital, London
University of Ankara, Ankara Turkey
First Affiliated Hospital of Soochow University, Suzhou
CHU Nantes, Nantes
CHU Bordeaux, F-33000, Bordeaux
Sheffield Blood and Marrow Transplant and Cellular Therapy Program, Department of Hematology, Sheffield Teaching Hospitals NHS Trust, Sheffield
Baskent University Hospital, Adana
A.O.R.N. 'SAN.G MOSCATI' Avellino
Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France and French Reference Center for Aplastic Anemia
Haematologica Early view May 18, 2023